New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish national diabetes register (NDR)
The primary aim of this study was to evaluate the reduction in major adverse cardiac events (MACE) associated with oral semaglutide compared with placebo in patients with type 2 diabetes (T2D) and established cardiovascular disease
Mechanisms Relevant to Formulators The ghk cu peptide influences hair follicles through several pathways: Microcirculation improvement : Enhanced blood flow around follicular structures DHT pathway modulation : Literature suggests potential effects on DHT-related mechanisms Extracellular matrix support : Maintains structural integrity around the follicle Anagen phase prolongation : Experimental models show extended growth phase duration Clinical Observations Small clinical and observational studies report measurable outcomes when GHK-Cu-containing lotions were applied over 3-6 months: Increased hair density Larger follicle size Reduced shedding Improved scalp condition Formulator-Ready Benefits Supports thicker-looking hair and stimulates hair growth Improves scalp condition and comfort Compatible with common anti-hair loss actives Suitable for sensitized or flaky scalps when combined with soothing agents GHK-Cu pairs effectively with niacinamide, panthenol, zinc PCA, and botanical extracts like rosemary and green tea for comprehensive scalp care systems
Patients with specific FTO variants, for example, may show stronger appetite suppression with higher-dose semaglutide, while those with certain GIPR polymorphisms might benefit from tirzepatide's dual GLP-1/GIP mechanism
It is highly suitable for extended experimental protocols and dose-response studies
Theres just one small problem: not a single randomized controlled trial has ever been completed in humans
02105-1/asset/8468e457-0c7f-4e4c-9b6d-2202dbefa9cb/main.assets/gr1_lrg.jpg)
